PlainRecalls
FDA Drug Moderate Class II Ongoing

Entecavir Tablets, USP, 0.5 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.

Reported: September 24, 2025 Initiated: September 4, 2025 #D-0656-2025

Product Description

Entecavir Tablets, USP, 0.5 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.

Reason for Recall

Failed Impurity/Degradation Specifications

Details

Units Affected
4344 bottles
Distribution
U.S. Nationwide
Location
Pennington, NJ

Frequently Asked Questions

What product was recalled?
Entecavir Tablets, USP, 0.5 mg, 30 Tablets, Rx Only, Manufactured by: Zydus Lifesciences Ltd., Ahmedabad, India, Distributed by: Zydus Pharmaceuticals (USA) Inc., Pennington, NJ 08534, NDC 68382-920-06.. Recalled by Zydus Pharmaceuticals (USA) Inc. Units affected: 4344 bottles.
Why was this product recalled?
Failed Impurity/Degradation Specifications
Which agency issued this recall?
This recall was issued by the FDA Drug on September 24, 2025. Severity: Moderate. Recall number: D-0656-2025.